IBJNews

Lilly seeks to block imports of cancer drug copy

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co. asked a U.S. trade agency on Thursday to block Hospira Inc. from selling a generic version of the cancer treatment Gemzar, saying the drug violates a patent on the process for making the active ingredient.

Lilly’s complaint to the U.S. International Trade Commission in Washington claims Hospira’s gemcitabine, Gemzar’s active ingredient, infringes a patent expiring in February 2014.

Global sales of Gemzar, used to treat lung, breast, pancreatic and ovarian cancer, fell about 14 percent to $905.8 million in the nine months ended in September, the Indianapolis-based company said Oct. 21.

Hospira began selling gemcitabine in November after Lilly lost an appeals court ruling that said a separate patent expiring in May 2013 was invalid.

The patented method is “the most commercially viable process available for manufacturing gemcitabine” and “involves less steps, higher yields and lower costs,” Lilly said in its complaint. Hospira has refused to provide records on the process it uses to make gemcitabine, according to the complaint.

Lilly is committed to protecting its intellectual property, Mark Taylor, a company spokesman, said in an e-mail Friday. Officials with Lake Forest, Ill.-based Hospira didn’t immediately return a message seeking comment.

The ITC has the power to bar imports of products that infringe U.S. patents and typically completes investigations in about 15 months.

Hospira sued Lilly in October. It’s seeking a court ruling that its process wouldn’t infringe the patent.

Lilly is facing generic competition for its three biggest products in the next two years: schizophrenia drug Zyprexa, antidepressant Cymbalta and the insulin Humalog. The three drugs generated $9.95 billion in 2009 sales, or about 46 percent of the company’s total revenue.
 

ADVERTISEMENT

  • idiots
    stop issuing patents for medicine that saves lives. the pharmcos will become extremely competitive, and diseaeses will be cured! this behavior only slows medical research to a crawl. for what? a billionaire's profit?

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT